Skip to main content
logo
Inovio Pharmaceuticals logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.040
+0.054 (5.48%)
At close: Oct 15, 2026, 4:00 PM EDT
1.030
-0.010 (-0.96%)
After-hours: Oct 15, 2026, 7:59 PM EDT

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%. That makes Inovio Pharmaceuticals the 46,354th largest company in the world by revenue and 6,901st in the United States.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
107.53M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Foghorn Therapeutics36.74M
Tonix Pharmaceuticals Holding29.10M
LENZ Therapeutics21.48M
Seer, Inc.14.22M
Coya Therapeutics8.02M
Milestone Pharmaceuticals2.34M
Genelux8.00K
Revenue Rankings

INO News

More News